Paul Keane

Paul Keane is a committed scientist with extensive experience in neuropharmacology, toxicology, and drug development. They held various roles at Roche, including Pipeline Lead and Medical Manager, where they contributed to significant projects in neuroscience and rare conditions. Previously, Paul worked at ICON plc as a Quality Assurance Auditor and held positions as a Toxicology Cellular Pathology Scientist and In-vivo Pre-Clinical Pharmacology Scientist, gaining expertise in regulatory documentation and clinical trial operations. Paul earned a PhD in Neurotoxicology from the University of Newcastle-upon-Tyne, focusing on the effects of trichloroethylene related to Parkinson’s disease.